Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non‐Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study
Summary Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom’s macroglobulinemia (WM) (named non‐WM LPL) is a rare disease and only a few systematic studies have been published. Here, we present a population‐based study of non‐WM LPL focusing on diagnost...
Uložené v:
| Vydané v: | British journal of haematology Ročník 196; číslo 6; s. 1362 - 1368 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Blackwell Publishing Ltd
01.03.2022
|
| Predmet: | |
| ISSN: | 0007-1048, 1365-2141, 1365-2141 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Summary
Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom’s macroglobulinemia (WM) (named non‐WM LPL) is a rare disease and only a few systematic studies have been published. Here, we present a population‐based study of non‐WM LPL focusing on diagnostic difficulties, patient characteristics, and outcome. From 1511 patients included in the Swedish Lymphoma Registry 1 Jan 2000 – 31 Dec 2014 with a diagnosis of WM/LPL, we could confirm the diagnosis of non‐WM LP in only 33 patients. The median age at diagnosis was 69 years. A paraprotein was found in most (IgG in 54%, IgA in 15%) and 12% of the cases were non‐secretory. Compared with the WM patients, the non‐WM LPL patients were younger, had more adverse prognostic factors such as elevated LDH, anaemia, and lymphocytosis at diagnosis. In addition, the non‐WM LPL patients more often were symptomatic and received treatment at diagnosis. The overall survival (OS) did not significantly differ between the non‐WM LPL and WM groups (P = 0.247), with a median survival time of 71 and 96 months, respectively. To conclude, we found differences in clinical features between WM and non‐WM LPL, but no difference in survival. |
|---|---|
| AbstractList | Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom’s macroglobulinemia (WM) (named non‐WM LPL) is a rare disease and only a few systematic studies have been published. Here, we present a population‐based study of non‐WM LPL focusing on diagnostic difficulties, patient characteristics, and outcome. From 1511 patients included in the Swedish Lymphoma Registry 1 Jan 2000 – 31 Dec 2014 with a diagnosis of WM/LPL, we could confirm the diagnosis of non‐WM LP in only 33 patients. The median age at diagnosis was 69 years. A paraprotein was found in most (IgG in 54%, IgA in 15%) and 12% of the cases were non‐secretory. Compared with the WM patients, the non‐WM LPL patients were younger, had more adverse prognostic factors such as elevated LDH, anaemia, and lymphocytosis at diagnosis. In addition, the non‐WM LPL patients more often were symptomatic and received treatment at diagnosis. The overall survival (OS) did not significantly differ between the non‐WM LPL and WM groups (P = 0.247), with a median survival time of 71 and 96 months, respectively. To conclude, we found differences in clinical features between WM and non‐WM LPL, but no difference in survival. Summary Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom’s macroglobulinemia (WM) (named non‐WM LPL) is a rare disease and only a few systematic studies have been published. Here, we present a population‐based study of non‐WM LPL focusing on diagnostic difficulties, patient characteristics, and outcome. From 1511 patients included in the Swedish Lymphoma Registry 1 Jan 2000 – 31 Dec 2014 with a diagnosis of WM/LPL, we could confirm the diagnosis of non‐WM LP in only 33 patients. The median age at diagnosis was 69 years. A paraprotein was found in most (IgG in 54%, IgA in 15%) and 12% of the cases were non‐secretory. Compared with the WM patients, the non‐WM LPL patients were younger, had more adverse prognostic factors such as elevated LDH, anaemia, and lymphocytosis at diagnosis. In addition, the non‐WM LPL patients more often were symptomatic and received treatment at diagnosis. The overall survival (OS) did not significantly differ between the non‐WM LPL and WM groups (P = 0.247), with a median survival time of 71 and 96 months, respectively. To conclude, we found differences in clinical features between WM and non‐WM LPL, but no difference in survival. Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom’s macroglobulinemia (WM) (named non-WM LPL) is a rare disease and only a few systematic studies have been published. Here, we present a population-based study of non-WM LPL focusing on diagnostic difficulties, patient characteristics, and outcome. From 1511 patients included in the Swedish Lymphoma Registry 1 Jan 2000 – 31 Dec 2014 with a diagnosis of WM/LPL, we could confirm the diagnosis of non-WM LP in only 33 patients. The median age at diagnosis was 69 years. A paraprotein was found in most (IgG in 54%, IgA in 15%) and 12% of the cases were non-secretory. Compared with the WM patients, the non-WM LPL patients were younger, had more adverse prognostic factors such as elevated LDH, anaemia, and lymphocytosis at diagnosis. In addition, the non-WM LPL patients more often were symptomatic and received treatment at diagnosis. The overall survival (OS) did not significantly differ between the non-WM LPL and WM groups (P = 0.247), with a median survival time of 71 and 96 months, respectively. To conclude, we found differences in clinical features between WM and non-WM LPL, but no difference in survival. Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom's macroglobulinemia (WM) (named non-WM LPL) is a rare disease and only a few systematic studies have been published. Here, we present a population-based study of non-WM LPL focusing on diagnostic difficulties, patient characteristics, and outcome. From 1511 patients included in the Swedish Lymphoma Registry 1 Jan 2000 - 31 Dec 2014 with a diagnosis of WM/LPL, we could confirm the diagnosis of non-WM LP in only 33 patients. The median age at diagnosis was 69 years. A paraprotein was found in most (IgG in 54%, IgA in 15%) and 12% of the cases were non-secretory. Compared with the WM patients, the non-WM LPL patients were younger, had more adverse prognostic factors such as elevated LDH, anaemia, and lymphocytosis at diagnosis. In addition, the non-WM LPL patients more often were symptomatic and received treatment at diagnosis. The overall survival (OS) did not significantly differ between the non-WM LPL and WM groups (P = 0.247), with a median survival time of 71 and 96 months, respectively. To conclude, we found differences in clinical features between WM and non-WM LPL, but no difference in survival.Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom's macroglobulinemia (WM) (named non-WM LPL) is a rare disease and only a few systematic studies have been published. Here, we present a population-based study of non-WM LPL focusing on diagnostic difficulties, patient characteristics, and outcome. From 1511 patients included in the Swedish Lymphoma Registry 1 Jan 2000 - 31 Dec 2014 with a diagnosis of WM/LPL, we could confirm the diagnosis of non-WM LP in only 33 patients. The median age at diagnosis was 69 years. A paraprotein was found in most (IgG in 54%, IgA in 15%) and 12% of the cases were non-secretory. Compared with the WM patients, the non-WM LPL patients were younger, had more adverse prognostic factors such as elevated LDH, anaemia, and lymphocytosis at diagnosis. In addition, the non-WM LPL patients more often were symptomatic and received treatment at diagnosis. The overall survival (OS) did not significantly differ between the non-WM LPL and WM groups (P = 0.247), with a median survival time of 71 and 96 months, respectively. To conclude, we found differences in clinical features between WM and non-WM LPL, but no difference in survival. |
| Author | Kimby, Eva Brandefors, Lena Sander, Birgitta Lundqvist, Kristina |
| Author_xml | – sequence: 1 givenname: Lena orcidid: 0000-0003-0765-1685 surname: Brandefors fullname: Brandefors, Lena email: Lena.Brandefors@norrbotten.se organization: Sunderby Hospital – sequence: 2 givenname: Birgitta orcidid: 0000-0002-1214-1340 surname: Sander fullname: Sander, Birgitta organization: Karolinska Institute – sequence: 3 givenname: Kristina surname: Lundqvist fullname: Lundqvist, Kristina organization: Umeå University – sequence: 4 givenname: Eva orcidid: 0000-0003-3078-6131 surname: Kimby fullname: Kimby, Eva organization: Karolinska Institute |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34959252$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-190982$$DView record from Swedish Publication Index (Umeå universitet) http://kipublications.ki.se/Default.aspx?queryparsed=id:148445573$$DView record from Swedish Publication Index (Karolinska Institutet) |
| BookMark | eNp9ks1u1DAUhS1URKeFBS-AIrGBRVrbsT0Ju2EoFFSJBX9Ly3buzHhw4tRONMquj9Bn5EnwkClIFeCNrevvHF_b5wQdtb4FhJ4SfEbSONfbzRkpMaYP0IwUgueUMHKEZhjjeU4wK4_RSYxbjEmBOXmEjgtW8YpyOkO3S2dba5TLzEYFZXoINvbWZKqtMz_0xjeQ-VXmxqbb-M6p2Cgz7oGp0qj9burnx83tN-VqaGMffJMlKvi183pI_tBYlfVjB6-yRfZpB7WNmz_6AOt0ZBiz2A_1-Bg9XCkX4clhPkVf3l58Xl7mVx_fvV8urnLDBKM5M1VZKVIbhRmuKS0wKCYU06ykojBM81poXZUlYyuMtSq4pqBNQYAzQoUoTlE--cYddIOWXbCNCqP0yspD6XtagWRcCFb-l39jvy6kD2s5NIMkFa5KmvgXE98Ffz1A7GVjowHnVAt-iJIKwgmZV7RK6PN76NYPoU23TxTDBeVzghP17EANuoH6dwN3f5mA8wlILx9jgJU0tle99W0flHWSYLlPi0xpkb_SkhQv7ynuTP_GHtx31sH4b1C-_nA5KX4CgCLR6g |
| CitedBy_id | crossref_primary_10_1007_s44178_024_00083_y crossref_primary_10_3892_ol_2024_14471 crossref_primary_10_1002_hon_3210 crossref_primary_10_1016_j_humpath_2022_10_005 crossref_primary_10_1053_j_seminhematol_2025_04_002 crossref_primary_10_1002_jha2_70027 crossref_primary_10_1002_ajh_27202 |
| Cites_doi | 10.1002/ajh.25600 10.1038/nature10113 10.3109/10428194.2015.1096357 10.1182/blood-2012-09-457101 10.1038/leu.2013.124 10.3324/haematol.2017.172718 10.1038/nature09671 10.1111/bjh.15558 10.1016/j.critrevonc.2008.03.008 10.1111/j.1541-0420.2011.01640.x 10.5045/br.2018.53.3.189 10.1093/biomet/69.3.553 10.1182/blood-2013-07-517037 10.18637/jss.v087.i08 10.1111/biom.12477 10.1016/0197-2456(96)00075-X 10.1038/bcj.2013.28 10.1093/ajcp/aqw072 10.1056/NEJMoa1200710 10.1182/blood-2018-99-114254 10.1200/EDBK_175447 10.1182/asheducation.V2012.1.586.3798562 |
| ContentType | Journal Article |
| Copyright | 2021 The Authors. published by British Society for Haematology and John Wiley & Sons Ltd. 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. 2021. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2021 The Authors. published by British Society for Haematology and John Wiley & Sons Ltd. – notice: 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. – notice: 2021. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 ADHXS ADTPV AOWAS D8T D93 ZZAVC |
| DOI | 10.1111/bjh.18002 |
| DatabaseName | Wiley Online Library Open Access (WRLC) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic SWEPUB Umeå universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Umeå universitet SwePub Articles full text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access (WRLC) url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1365-2141 |
| EndPage | 1368 |
| ExternalDocumentID | oai_swepub_ki_se_456648 oai_DiVA_org_umu_190982 34959252 10_1111_bjh_18002 BJH18002 |
| Genre | article Journal Article |
| GeographicLocations | Sweden |
| GeographicLocations_xml | – name: Sweden |
| GrantInformation_xml | – fundername: Norrbottens Läns Landsting |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1KJ 1OB 1OC 23N 24P 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYEP AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AI. AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EGARE EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IH2 IHE IX1 J0M J5H K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K V9Y VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X CGR CUY CVF ECM EIF NPM 7T5 H94 K9. 7X8 ADHXS ADTPV AOWAS D8T D93 ZZAVC |
| ID | FETCH-LOGICAL-c4642-4c989a1dca040d2230ea46a4b48263c4b5d6bb98844f00ba35b2ebc31e5412663 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 8 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000734614200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0007-1048 1365-2141 |
| IngestDate | Tue Nov 25 03:38:07 EST 2025 Tue Nov 04 17:01:19 EST 2025 Sun Nov 09 09:20:30 EST 2025 Mon Oct 06 18:24:39 EDT 2025 Thu Apr 03 06:59:51 EDT 2025 Sat Nov 29 02:02:54 EST 2025 Tue Nov 18 21:31:33 EST 2025 Wed Jan 22 16:25:40 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | epidemiology clinical aspects risk factors lymphoplasmacytic lymphoma |
| Language | English |
| License | Attribution-NonCommercial 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4642-4c989a1dca040d2230ea46a4b48263c4b5d6bb98844f00ba35b2ebc31e5412663 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-1214-1340 0000-0003-3078-6131 0000-0003-0765-1685 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbjh.18002 |
| PMID | 34959252 |
| PQID | 2640325710 |
| PQPubID | 36395 |
| PageCount | 7 |
| ParticipantIDs | swepub_primary_oai_swepub_ki_se_456648 swepub_primary_oai_DiVA_org_umu_190982 proquest_miscellaneous_2615117929 proquest_journals_2640325710 pubmed_primary_34959252 crossref_citationtrail_10_1111_bjh_18002 crossref_primary_10_1111_bjh_18002 wiley_primary_10_1111_bjh_18002_BJH18002 |
| PublicationCentury | 2000 |
| PublicationDate | March 2022 |
| PublicationDateYYYYMMDD | 2022-03-01 |
| PublicationDate_xml | – month: 03 year: 2022 text: March 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Oxford |
| PublicationTitle | British journal of haematology |
| PublicationTitleAlternate | Br J Haematol |
| PublicationYear | 2022 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | 1982; 69 2018; 132 2012; 2012 1996; 17 2019; 94 2018; 183 2017; 37 2016; 145 2008; 67 2016; 72 2013; 121 2014; 28 2012; 367 2011; 470 2012; 68 2018; 87 2017; 102 2013; 6 2018; 53 2011; 475 2016; 57 2014; 123 e_1_2_5_27_1 e_1_2_5_25_1 e_1_2_5_26_1 e_1_2_5_23_1 e_1_2_5_24_1 e_1_2_5_21_1 e_1_2_5_22_1 e_1_2_5_20_1 e_1_2_5_15_1 e_1_2_5_14_1 e_1_2_5_17_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 |
| References_xml | – volume: 68 start-page: 113 issue: 1 year: 2012 end-page: 120 article-title: On estimation in relative survival publication-title: Biometrics – volume: 37 start-page: 505 year: 2017 end-page: 11 article-title: Age and sex in non‐Hodgkin lymphoma therapy: it's not all created equal, or is it? publication-title: Am Soc Clin Oncol Educ Book – volume: 67 start-page: 172 issue: 2 year: 2008 end-page: 85 article-title: Lymphoplasmacytic lymphoma‐Waldenstrom's macroglobulinemia publication-title: Crit Rev Oncol Hematol – volume: 470 start-page: 115 issue: 7332 year: 2011 end-page: 9 article-title: Oncogenically active MYD88 mutations in human lymphoma publication-title: Nature – volume: 145 start-page: 843 issue: 6 year: 2016 end-page: 51 article-title: Lymphoplasmacytic lymphoma with a non‐IgM paraprotein shows clinical and pathologic heterogeneity and may harbor MYD88 L265P mutations publication-title: Am J Clin Pathol – volume: 102 start-page: 2077 issue: 12 year: 2017 end-page: 85 article-title: Pattern of somatic mutations in patients with Waldenstrom macroglobulinemia or IgM monoclonal gammopathy of undetermined significance publication-title: Haematologica – volume: 72 start-page: 760 issue: 3 year: 2016 end-page: 69 article-title: A log‐rank‐type test to compare net survival distributions publication-title: Biometrics – volume: 121 start-page: 2522 issue: 13 year: 2013 end-page: 8 article-title: Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms publication-title: Blood – volume: 53 start-page: 189 issue: 3 year: 2018 end-page: 97 article-title: Clinical features and survival outcomes of patients with lymphoplasmacytic lymphoma, including non‐IgM type, in Korea: a single‐center experience publication-title: Blood Res – volume: 123 start-page: 640 issue: 5 year: 2014 end-page: 6 article-title: Suboptimal dosing of rituximab in male and female patients with DLBCL publication-title: Blood – volume: 28 start-page: 166 issue: 1 year: 2014 end-page: 73 article-title: Multiparameter flow cytometry for the identification of the Waldenstrom's clone in IgM‐MGUS and Waldenstrom's Macroglobulinemia: new criteria for differential diagnosis and risk stratification publication-title: Leukemia – volume: 367 start-page: 826 issue: 9 year: 2012 end-page: 33 article-title: MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia publication-title: N Engl J Med – volume: 6 start-page: e139 issue: 3 year: 2013 article-title: High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B‐cell lymphomas presenting at immune‐privileged sites publication-title: Blood Cancer J – volume: 69 start-page: 553 year: 1982 end-page: 66 article-title: A class of rank test procedures for censored survival data publication-title: Biometrika – volume: 94 start-page: 1193 issue: 11 year: 2019 end-page: 9 article-title: Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: a multicentric study of the Rete Ematologica Lombarda (REL) network publication-title: Am J Hematol – volume: 132 start-page: 2886 year: 2018 article-title: Non‐IgM Secreting Lymphoplasmacytic Lymphoma ‐ Experience of a Reference Center for Waldenstrom Macroglobulinemia. ASH annual meeting 2018 publication-title: Blood – volume: 17 start-page: 343 issue: 4 year: 1996 end-page: 6 article-title: A Note on quantifying follow‐up in studies of failure time publication-title: Control Clin Trials – volume: 57 start-page: 1104 issue: 5 year: 2016 end-page: 13 article-title: Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression publication-title: Leuk Lymphoma – volume: 475 start-page: 101 issue: 7354 year: 2011 end-page: 5 article-title: Whole‐genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia publication-title: Nature – volume: 2012 start-page: 586 year: 2012 end-page: 94 article-title: Are you sure this is Waldenstrom macroglobulinemia? publication-title: Hematology Am Soc Hematol Educ Program – volume: 183 start-page: 564 issue: 4 year: 2018 end-page: 77 article-title: Prognostic factors and primary treatment for Waldenstrom macroglobulinemia ‐ a Swedish Lymphoma Registry study publication-title: Br J Haematol – volume: 87 start-page: 1 issue: 8 year: 2018 end-page: 27 article-title: Nonparametric relative survival analysis with the R PACKAGE relsurv publication-title: J Stat Softw – ident: e_1_2_5_3_1 doi: 10.1002/ajh.25600 – ident: e_1_2_5_15_1 – ident: e_1_2_5_8_1 doi: 10.1038/nature10113 – ident: e_1_2_5_11_1 doi: 10.3109/10428194.2015.1096357 – ident: e_1_2_5_4_1 doi: 10.1182/blood-2012-09-457101 – ident: e_1_2_5_17_1 – ident: e_1_2_5_23_1 doi: 10.1038/leu.2013.124 – ident: e_1_2_5_25_1 doi: 10.3324/haematol.2017.172718 – ident: e_1_2_5_5_1 doi: 10.1038/nature09671 – ident: e_1_2_5_14_1 doi: 10.1111/bjh.15558 – ident: e_1_2_5_9_1 doi: 10.1016/j.critrevonc.2008.03.008 – ident: e_1_2_5_19_1 doi: 10.1111/j.1541-0420.2011.01640.x – ident: e_1_2_5_12_1 doi: 10.5045/br.2018.53.3.189 – ident: e_1_2_5_18_1 doi: 10.1093/biomet/69.3.553 – ident: e_1_2_5_27_1 doi: 10.1182/blood-2013-07-517037 – ident: e_1_2_5_16_1 doi: 10.18637/jss.v087.i08 – ident: e_1_2_5_20_1 doi: 10.1111/biom.12477 – ident: e_1_2_5_22_1 doi: 10.1016/0197-2456(96)00075-X – ident: e_1_2_5_6_1 doi: 10.1038/bcj.2013.28 – ident: e_1_2_5_7_1 doi: 10.1093/ajcp/aqw072 – ident: e_1_2_5_24_1 doi: 10.1056/NEJMoa1200710 – ident: e_1_2_5_21_1 – ident: e_1_2_5_13_1 doi: 10.1182/blood-2018-99-114254 – ident: e_1_2_5_2_1 – ident: e_1_2_5_26_1 doi: 10.1200/EDBK_175447 – ident: e_1_2_5_10_1 doi: 10.1182/asheducation.V2012.1.586.3798562 |
| SSID | ssj0013051 |
| Score | 2.4214814 |
| Snippet | Summary
Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom’s macroglobulinemia (WM) (named non‐WM LPL) is a... Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom’s macroglobulinemia (WM) (named non‐WM LPL) is a rare... Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom's macroglobulinemia (WM) (named non-WM LPL) is a rare... Lymphoplasmacytic lymphoma (LPL) not fulfilling the WHO diagnostic criteria (2017) for Waldenstrom’s macroglobulinemia (WM) (named non-WM LPL) is a rare... |
| SourceID | swepub proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1362 |
| SubjectTerms | clinical aspects Diagnosis epidemiology Hematology Humans Immunoglobulin A Immunoglobulin G Lymphocytosis Lymphoma Lymphoma, B-Cell lymphoplasmacytic lymphoma Macroglobulinemia Medical prognosis Medical treatment Patients Population studies Rare diseases Registries risk factors Survival Sweden - epidemiology Waldenstrom Macroglobulinemia - drug therapy |
| Title | Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non‐Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbjh.18002 https://www.ncbi.nlm.nih.gov/pubmed/34959252 https://www.proquest.com/docview/2640325710 https://www.proquest.com/docview/2615117929 https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-190982 http://kipublications.ki.se/Default.aspx?queryparsed=id:148445573 |
| Volume | 196 |
| WOSCitedRecordID | wos000734614200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1365-2141 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0013051 issn: 1365-2141 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1365-2141 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0013051 issn: 1365-2141 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dbtMwFLamDSFuYPwXxmQQQtwExY6TOOyqMKqBoJqAsd5ZtuOwQpNMaQPa3R5hz7gn4dhxMyqYhMRNlMQniROfn8-x_R2EnkLUo1SlJiiojAMmiQlUGpuAGpPEEDGKXOYu2UQ6HvPJJNtfQzvLtTAdP0T_w81ahvPX1sClmv9m5Orb0QvCHZHkBiERt3kbKNu_GEIIY58uLwVfw7inFbLTePpLV4PRHwizpw9dRa4u9Ixu_FelN9F1jzjxsFORm2jNVLfQ1Q9-TP02OvPUoDOsV8ibsaxyXLcLeITBdYFnJ9Dw9TGg7VLqEyvQnSmlLa3q6vz07FDOwI_NF01dYpBqass3Yue6m3Iqsf3d-xIP8aefdjHw0cX1NjuETTqHHdntHXQwevP59V7g8zQEmkH3JWA645kkuZbgEXLAG6GRLJFMMei7RJqpOE-UyjhnrAhDJaNYUaN0REzMCACE6C5ah1qa-whnvGAxxG0DwIxRQKfgLxKuJeGFAWXKBuj5ssGE9iTmNpfGTCw7M_CFhfvCA_SkFz3umDv-JrS1bHXhjXcuACOGEbgyEg7Q474YzM6OpcjK1K2VAagElaNQpXudtvRPiaDTmdEYbv6sU5--xHJ5706_DEXdfBVt2QqAYxm_RNCf-g57RgDOTRiH13fadfkLiVfv9tzOg38XfYiuUbuow82s20Lri6Y1j9AV_WMxnTfbzqpgm074NtrY_Tg6eA9Hh2_HvwBXeiwA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFLWqgoAN78dAAYMQYpMqceyMg9gMj2oK7QiJQruzbMehA5OkykxA3fEJ_Ua-hHudTMoIKiGxi-KbxI7v4_h1LiFPIOoxZoYuyJkWAdeRC8xQuIA5lwiIGHmmM59sYjiZyIOD9P0aebE8C9PyQ_QTbmgZ3l-jgeOE9G9Wbr4cbkbSM0me4wA0MHHD_vbkdA0hFF2-vCE4Gy47XiHcx9M_uhqN_oCYPX_oKnT1sWfryv_V-iq53GFOOmqV5BpZc-V1cmG3W1W_QU46ctAZtSv0zVSXGa2aBXzD0Sqns2Po-uoI8Hah7TEKtHcKjaVlVf78cbKvZ-DJ5ou6KihI1RUyjuBud1dMNcUJ3-d0RD98x-PAh6fPY34ITDtHPd3tTfJx683eq3HQZWoILIcBTMBtKlMdZVaDT8gAcYRO80Rzw2H0EltuRJYYk0rJeR6GRsfCMGdsHDnBI4AI8S2yDrV0dwhNZc4FRG4H0IwzwKfgMRJpdSRzB-qUDsizZY8p29GYYzaNmVoOZ-APK_-HB-RxL3rUcnf8TWhj2e2qM9-5ApQYxuDMonBAHvXFYHi4mqJLVzUoA2AJKsegSrdbdem_EsOwM2UCXv601Z--BNm8X08_jVRVf1ZN0SgAZKk8Q7C79RWunAKkm3AJzffqdXaD1Mu3Y39x999FH5KL473dHbWzPXl3j1xieMTD77PbIOuLunH3yXn7bTGd1w-8if0CWSgswQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLamDk28cL8UBhiEEC9BiWOnDuKlUKoBo5qAwd4s23FYtyap0ga0N37CfiO_hGPHzahgEhJvUXycOPa5fI7t7yD0GKIeIWpggpxIFlAZmUANmAmIMQmDiJFnMnPJJgaTCT84SPc20IvVWZiWH6L74WYtw_lra-BmnuW_Wbk6OnwWccckuUltEpke2hx9GO_vnq0ihMxnzBuAu6HcMwvZnTxd5fV49AfI7BhE18Griz7jy__X7ivokkedeNiqyVW0YcpraOu9X1e_jk49PegM6zUCZyzLDFfNEt5hcJXj2QkMfjUHxF1IfWIF2juFtKVlVf78cfpFzsCXLZZ1VWCQqivLOWL3u5tiKrH95fscD_HH7_ZA8OFZfZshwiaew47w9gbaH7_-9Gon8LkaAk1hChNQnfJURpmW4BUywByhkTSRVFGYv8SaKpYlSqWcU5qHoZIxU8QoHUeG0QhAQnwT9aCV5jbCKc8pg9htAJxRAggVfEbCtYx4bkCh0j56uhoxoT2Ruc2nMROrCQ30sHA93EePOtF5y97xN6Ht1bALb8ALATgxjMGdRWEfPeyKwfTseoosTdVYGYBL0DgCTbrVqkv3lhgmnilh8PAnrf50JZbPezT9PBRV_VU0RSMAkqX8HEF_6xiujACsm1AOn-_U6_wPEi_f7riLO_8u-gBt7Y3GYvfN5N1ddJHYMx5uo9026i3rxtxDF_S35XRR3_c29gtZfy1q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+characteristic+and+outcome+of+lymphoplasmacytic+lymphoma+of+non%E2%80%90Waldenstrom+macroglobulinemia+type%3A+A+Swedish+lymphoma+registry+study&rft.jtitle=British+journal+of+haematology&rft.au=Brandefors%2C+Lena&rft.au=Sander%2C+Birgitta&rft.au=Lundqvist%2C+Kristina&rft.au=Kimby%2C+Eva&rft.date=2022-03-01&rft.issn=0007-1048&rft.eissn=1365-2141&rft.volume=196&rft.issue=6&rft.spage=1362&rft.epage=1368&rft_id=info:doi/10.1111%2Fbjh.18002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_bjh_18002 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1048&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1048&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1048&client=summon |